InvestorsHub Logo
Post# of 4970011
Next 10
Followers 18
Posts 2604
Boards Moderated 0
Alias Born 10/12/2009

Re: None

Tuesday, 06/22/2021 9:33:56 AM

Tuesday, June 22, 2021 9:33:56 AM

Post# of 4970011
Roth Capital analyst Elemer Piros initiates coverage on Mydecine Innovations (NEO: MYCO) with a Buy rating and announces Price Target of C$3.

All my posts are OPINION only. Never buy or sell securities based on my opinion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.